Key facts
- This page summarizes Roger Jeffs's Form 4 filing for Axsome Therapeutics, Inc. (AXSM).
- 2 reported transactions and 2 derivative rows are listed below.
- Accepted by SEC: 10 Jun 2025, 19:00.
Roger Jeffs - 06 Jun 2025 Form 4 Insider Report for Axsome Therapeutics, Inc. (AXSM)
- Reporting relationship
- Director
- Issuer ticker
- AXSM
- Reported as of
- 06 Jun 2025
- Net transaction value
- $0
- SEC form
- 4
- Accepted by SEC
- 10 Jun 2025, 19:00:19 UTC
- Prior SEC filing
- 05 Jun 2025
- Next SEC filing
- 15 Jul 2025
- Source filing
- View source filing
- Reporting owner signature
- /s/ Nick Pizzie, Attorney-in-Fact
Source evidence
Original filing metadata and source links for verification.
5 source fields
Reporting owner
1 detail
Key filing fact
Roger Jeffs filed Form 4 for Axsome Therapeutics, Inc. (AXSM) on 10 Jun 2025.
Change
- Previous filing in this sequence was filed on 05 Jun 2025.
- Current net transaction value: $0.
Research use
- This tells you what this filing adds before you inspect full transaction and derivative tables.
- You can trace every row back to the original SEC filing document.
Evidence
Filed on Form 4
View source filing
Ownership activity is grounded in SEC Form 4 disclosures.
Reporting Owners (1)
CIK 0001231615
Primary reporting owner
JEFFS ROGER
- Relationship
- Director
- Address
- C/O AXSOME THERAPEUTICS, INC., ONE WORLD TRADE CENTER, 29TH FLOOR, NEW YORK
- Signature
- /s/ Nick Pizzie, Attorney-in-Fact
- Signature date
- 10 Jun 2025
Reported derivative securities
Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.
AXSM
transaction
Derivative
Stock Option (Right to Buy)
Award
- Transaction value
- $0
- Shares
- +3,166
- Change %
- Price
- $0.000000
- Shares after
- 3,166
- Date
- 06 Jun 2025
- Ownership
- Direct
- Underlying class
- Common Stock
- Underlying amount
- 3,166
- Exercise price
- $111.91
- Footnotes
- F1
AXSM
transaction
Derivative
Restricted Stock Units
Award
- Transaction value
- $0
- Shares
- +1,429
- Change %
- Price
- $0.000000
- Shares after
- 1,429
- Date
- 06 Jun 2025
- Ownership
- Direct
- Underlying class
- Common Stock
- Underlying amount
- 1,429
- Exercise price
- Footnotes
- F2, F3
* marks a reported price that did not pass the local price check.
Additional SEC filing notes
Filing notes and footnotes
Explanation of responses 3 footnotes
Footnote F1
The options vest in full on the one-year anniversary of the date of grant, June 6, 2026.
Footnote F2
Each restricted stock unit ("RSU") represents a contingent right to receive one share of the Issuer's common stock.
Footnote F3
The RSUs vest in full on the one-year anniversary of the date of grant, June 6, 2026.